LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.521del
PTEN
· NP_000305.3:p.(Tyr174LeufsTer9)
· NM_000314.8
GRCh37: chr10:89711902 TA>T
·
GRCh38: chr10:87952145 TA>T
Gene:
PTEN
Transcript:
NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Tyr174LeufsTer9)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 very strong: the frameshift is 5′ of PTEN p.D375/c.1121 and meets the Expert Panel's nonsense-mediated-decay rule.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1, below the PTEN population-frequency threshold.
Final determination:
PTEN Expert Panel Rule20 classifies a variant as Likely Pathogenic when one Pathogenic.Very Strong criterion and one Pathogenic.Supporting criterion are met; here these are PVS1 very strong and PM2 supporting.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met at very strong strength: NM_000314.8:c.521del causes p.(Tyr174LeufsTer9), a frameshift 5′ of p.D375/c.1121, meeting the PTEN VCEP NMD branch. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | N/A | Not applicable: c.521del is a frameshift producing p.(Tyr174LeufsTer9), not a missense or splice-site variant eligible for the PTEN VCEP PS1 rule. |
cspec
|
| PS2 | Not assessed | Not assessed: no proband diagnosis, parental testing, maternity/paternity confirmation, or family-history data are documented. |
cspec
|
| PS3 | Not assessed | Not assessed: the PTEN VCEP assay table is restricted to missense variants, and no c.521del or p.Tyr174LeufsTer9 entry was found. |
cspec
vcep_mmc2
PMID:11237521
PMID:17218262
|
| PS4 | Not assessed | Not assessed: no case-control enrichment, confidence interval, or variant-specific phenotype score is available for applying the PTEN PS4 thresholds. |
cspec
|
| PM1 | Not assessed | Not assessed: PTEN Y174 is reported as a hotspot, but the partial hotspot source lacks a valid source_registry key required to audit PM1 evidence. |
cspec
|
| PM2 | Met | Met, supporting: the variant is absent (observed allele frequency 0) in gnomAD v2.1 and v4.1, below the PTEN PM2 threshold of 0.00001. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP explicitly excludes PM3 for this autosomal dominant disorder. |
cspec
|
| PM4 | N/A | Not applicable: the PTEN VCEP PM4 rule covers in-frame indels or stop-loss variants, whereas c.521del is a frameshift. |
cspec
|
| PM5 | N/A | Not applicable: c.521del is a frameshift producing p.(Tyr174LeufsTer9), whereas PM5 requires a missense change and a same-residue missense comparator. |
cspec
|
| PM6 | Not assessed | Not assessed: no qualifying assumed de novo observation, proband disease documentation, family history, or count of independent observations is available. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, co-segregation observations, family structure, or meiosis count are documented. |
cspec
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, while c.521del is a PTEN frameshift producing p.(Tyr174LeufsTer9). |
cspec
|
| PP3 | N/A | Not applicable: NM_000314.8:c.521del is a frameshift variant, outside PP3's missense or intronic/splice-region computational-evidence scope. |
cspec
pvs1_variant_assessment
|
| PP4 | N/A | Not applicable: the PTEN Expert Panel incorporates phenotype specificity into PS4 and explicitly excludes PP4. |
cspec
|
| PP5 | N/A | Not applicable: ClinVar has no exact-variant expert-panel pathogenic classification, and the PTEN framework excludes PP5. |
cspec
clinvar
|
| BA1 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the PTEN BA1 threshold of 0.00056 (0.056%). |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: the variant is absent from gnomAD, so its frequency does not fall within the PTEN BS1 interval of 0.0000043–0.00056. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not assessed | Not assessed: no confirmed homozygous observation in a healthy or PHTS-unaffected individual is available for this absent variant. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no applicable benign functional assay was found, and the governing PTEN table contains no entry for this frameshift variant. |
cspec
vcep_mmc2
PMID:11237521
PMID:17218262
|
| BS4 | Not assessed | Not assessed: no non-segregating affected relatives, family segregation results, or number of families are documented. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN VCEP marks BP1 as not applicable, and c.521del is a frameshift producing p.(Tyr174LeufsTer9). |
cspec
|
| BP2 | Not assessed | Not assessed: no second pathogenic PTEN variant or cis/trans phase observation is documented for the required BP2 evidence. |
cspec
|
| BP3 | N/A | Not applicable: the PTEN VCEP lists BP3 as not applicable, and c.521del is a frameshift rather than an in-frame repeat-region deletion. |
cspec
|
| BP4 | N/A | Not applicable: NM_000314.8:c.521del is a frameshift variant, outside BP4's missense or intronic/splice-region computational-evidence scope. |
cspec
pvs1_variant_assessment
|
| BP5 | Not assessed | Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN history are documented. |
cspec
|
| BP6 | N/A | Not applicable: the PTEN Expert Panel excludes BP6 and ClinVar has no exact-variant expert-panel benign classification. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: NM_000314.8:c.521del is a frameshift variant, not a synonymous variant eligible for BP7. |
cspec
pvs1_variant_assessment
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.